p53 loss does not permit escape from BrafV600E-induced senescence in a mouse model of lung cancer
Authors:
- 24 July 2017
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 36 (45) , 6325-6335
Abstract
Lung cancer arises through the acquisition of a number of genetic lesions, with a preponderance of activating mutations in the canonical mitogen-activated protein kinase (MAPK) cascade (RTK-RAS-RAF-MEK). BrafV600E expression induces benign lung adenomas that fail to progress to adenocarcinoma because of oncogene-induced senescence (OIS). BrafV600E expression, coupled with simultaneous p53 ablation, permits bypass of senescence and progression to lung adenocarcinoma. However, spontaneous human tumors sustain mutations in a temporally separated manner. Here, we use a mouse lung cancer model where oncogene activation (BrafV600E expression) and tumor suppressor loss (p53 ablation) are independently controlled through the actions of Flp and Cre recombinase, respectively. We show that p53 loss before OIS is permissive for the transition from lung adenoma to adenocarcinoma. In contrast, p53 loss after senescence is established fails to enable escape from senescence and disease progression. This study demonstrates that BrafV600E induced senescence is irreversible in vivo and suggests that therapy-induced senescence would halt further tumor progression.Keywords
This publication has 86 references indexed in Scilit:
- Chemotherapy Resistance in Lung Cancer2015
- Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAFOncogene, 2015
- How to calculate sample size in animal studies?Journal of Pharmacology and Pharmacotherapeutics, 2013
- Thrombospondin-1 mediates oncogenic Ras–induced senescence in premalignant lung tumorsJournal of Clinical Investigation, 2013
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel SequencingCell, 2012
- The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor SuppressionAnnual Review of Pathology: Mechanisms of Disease, 2010
- Divorcing ARF and p53: an unsettled caseNature Reviews Cancer, 2006
- The Differential Effects of Mutant p53 Alleles on Advanced Murine Lung CancerCancer Research, 2005
- Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasGenes & Development, 2001
- Generalized lacZ expression with the ROSA26 Cre reporter strainNature Genetics, 1999